RYLPF
Price
$26.84
Change
+$0.34 (+1.28%)
Updated
Aug 7 closing price
Capitalization
25.53B
SRTS
Price
$3.17
Change
-$0.29 (-8.38%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
56.98M
87 days until earnings call
Interact to see
Advertisement

RYLPF vs SRTS

Header iconRYLPF vs SRTS Comparison
Open Charts RYLPF vs SRTSBanner chart's image
Koninklijke Philips N.V
Price$26.84
Change+$0.34 (+1.28%)
Volume$155
Capitalization25.53B
Sensus Healthcare
Price$3.17
Change-$0.29 (-8.38%)
Volume$3.78K
Capitalization56.98M
RYLPF vs SRTS Comparison Chart in %
Loading...
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYLPF vs. SRTS commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLPF is a Hold and SRTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (RYLPF: $26.84 vs. SRTS: $3.46)
Brand notoriety: RYLPF and SRTS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RYLPF: 29% vs. SRTS: 1058%
Market capitalization -- RYLPF: $25.53B vs. SRTS: $56.98M
RYLPF [@Medical/Nursing Services] is valued at $25.53B. SRTS’s [@Medical/Nursing Services] market capitalization is $56.98M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.71B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYLPF’s FA Score shows that 1 FA rating(s) are green whileSRTS’s FA Score has 1 green FA rating(s).

  • RYLPF’s FA Score: 1 green, 4 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, RYLPF is a better buy in the long-term than SRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYLPF’s TA Score shows that 4 TA indicator(s) are bullish while SRTS’s TA Score has 4 bullish TA indicator(s).

  • RYLPF’s TA Score: 4 bullish, 3 bearish.
  • SRTS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RYLPF is a better buy in the short-term than SRTS.

Price Growth

RYLPF (@Medical/Nursing Services) experienced а -4.15% price change this week, while SRTS (@Medical/Nursing Services) price change was -37.90% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.73%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was +3.98%.

Reported Earning Dates

SRTS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.73% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYLPF($25.5B) has a higher market cap than SRTS($57M). RYLPF has higher P/E ratio than SRTS: RYLPF (143.84) vs SRTS (31.50). RYLPF YTD gains are higher at: 6.289 vs. SRTS (-49.928). RYLPF has higher annual earnings (EBITDA): 2.41B vs. SRTS (3.02M). RYLPF has more cash in the bank: 1.82B vs. SRTS (19.1M). SRTS has less debt than RYLPF: SRTS (654K) vs RYLPF (8.43B). RYLPF has higher revenues than SRTS: RYLPF (17.9B) vs SRTS (39.5M).
RYLPFSRTSRYLPF / SRTS
Capitalization25.5B57M44,737%
EBITDA2.41B3.02M79,973%
Gain YTD6.289-49.928-13%
P/E Ratio143.8431.50457%
Revenue17.9B39.5M45,316%
Total Cash1.82B19.1M9,550%
Total Debt8.43B654K1,288,379%
FUNDAMENTALS RATINGS
RYLPF vs SRTS: Fundamental Ratings
RYLPF
SRTS
OUTLOOK RATING
1..100
5071
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9087
PRICE GROWTH RATING
1..100
5092
P/E GROWTH RATING
1..100
1317
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RYLPF's Valuation (48) in the null industry is in the same range as SRTS (67) in the Medical Specialties industry. This means that RYLPF’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as RYLPF (100) in the null industry. This means that SRTS’s stock grew similarly to RYLPF’s over the last 12 months.

SRTS's SMR Rating (87) in the Medical Specialties industry is in the same range as RYLPF (90) in the null industry. This means that SRTS’s stock grew similarly to RYLPF’s over the last 12 months.

RYLPF's Price Growth Rating (50) in the null industry is somewhat better than the same rating for SRTS (92) in the Medical Specialties industry. This means that RYLPF’s stock grew somewhat faster than SRTS’s over the last 12 months.

RYLPF's P/E Growth Rating (13) in the null industry is in the same range as SRTS (17) in the Medical Specialties industry. This means that RYLPF’s stock grew similarly to SRTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RYLPFSRTS
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
49%
Bearish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 15 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
62%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNYA0.670.01
+0.86%
Tenaya Therapeutics
RNAZ10.65N/A
N/A
TransCode Therapeutics Inc
USFD80.06-0.11
-0.14%
US Foods Holding Corp
JOYY50.65-0.35
-0.69%
JOYY Inc
TYRA10.45-0.30
-2.79%
Tyra Biosciences

RYLPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with MTD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYLPF
1D Price
Change %
RYLPF100%
N/A
MTD - RYLPF
38%
Loosely correlated
+1.54%
CDNA - RYLPF
28%
Poorly correlated
-0.83%
MBGNF - RYLPF
24%
Poorly correlated
N/A
SRTS - RYLPF
23%
Poorly correlated
-35.23%
WRBY - RYLPF
21%
Poorly correlated
-0.64%
More

SRTS and

Correlation & Price change

A.I.dvisor tells us that SRTS and HOLX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRTS and HOLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-35.23%
HOLX - SRTS
27%
Poorly correlated
+0.19%
BFLY - SRTS
27%
Poorly correlated
-4.32%
MYO - SRTS
27%
Poorly correlated
+2.23%
MTD - SRTS
26%
Poorly correlated
+1.54%
PLSE - SRTS
26%
Poorly correlated
-0.07%
More